Septerna
Septerna is a biotechnology company dedicated to developing medicines targeting G protein-coupled receptors using innovative platform technology. The company focuses on discovering and advancing small molecule therapeutics for unmet medical needs through research and collaboration.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Septerna is a biotechnology company developing GPCR-targeted medicines using its Native Complex Platform to discover and advance innovative therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Septerna.
Analysts Conflicted on These Technology Names: Fortinet (FTNT), Septerna, Inc. (SEPN) and Oracle (ORCL)
4 days ago
Scientist, Analytical Sciences
Varda Space Industries
Senior Scientist 1, Analytical Development
Crinetics Pharmaceuticals
Director/Senior Director, Analytical Development
Orna Therapeutics
Principal Scientist, Analytical Sciences
Eli Lilly and Company
Director, Analytical Development
Crinetics Pharmaceuticals
Advisor - Analytical Chemistry
Eli Lilly and Company